Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine versus fexofenadine crossover trial in allergic rhinitis
IRCT20160516027929N11Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of desloratadine and fexofenadine in allergic rhinitis (AR) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Clinical symptoms. Started Apr 2021; status: completed.
02
Drugs
desloratadinefexofenadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20160516027929N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160516027929N11.